Study to Evaluate the Ocular Tolerance of SYL1001 in Healthy Volunteers

NCT01438281 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Pain
Dry Eye

Interventions

DRUG: SYL1001

Sponsor

Sylentis, S.A.